Subscribe to RSS
DOI: 10.1055/a-2781-6377
First-Trimester Machine Learning to Predict Preeclampsia in Normotensive Pregnancies by American Heart Association Guidelines
Authors
Funding Information The study was funded by the U.S. Department of Health and Human Services, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant no.: HD08631301).
Abstract
Objective
This study aimed to determine whether unsupervised machine learning can identify phenotypically distinct subgroups at increased risk for preeclampsia among pregnant individuals with American Heart Association (AHA)-defined normal blood pressure in the first trimester.
Methods
This was a secondary analysis of a prospective cohort study of singleton pregnancies enrolled at ≤136/7 weeks' gestation at two academic centers. Participants with prepregnancy chronic hypertension or major fetal/placental abnormalities were excluded. First-trimester blood pressure was categorized using the 2017 AHA guidelines. Among individuals with AHA-defined normal blood pressure (<120/80 mm Hg), unsupervised machine learning (k-means clustering) was applied to systolic, diastolic, and mean arterial pressure to identify distinct hemodynamic phenotypes. The primary outcome was preeclampsia; secondary outcomes included hypertensive disorders of pregnancy (HDP) and small-for-gestational age (SGA) neonates. Associations were assessed using multivariable Cox regression and Kaplan–Meier analyses.
Results
Of 570 participants, 378 (66.3%) had AHA-normal blood pressure. Among these, machine learning identified a high-risk cluster (7.4%) and a low-risk cluster (92.6%). Despite normotensive values, individuals in the high-risk cluster had a significantly higher incidence of preeclampsia (25.0 vs. 3.1%; p < 0.001) and HDP (28.6 vs. 5.7%; p < 0.001) compared to the low-risk cluster. After adjustment, the high-risk normotensive cluster had an eight-fold increased hazard of preeclampsia (adjusted hazard ratio [aHR] = 8.01; 95% CI: 3.09–20.74) and increased risk of SGA (adjusted odds ratio [aOR] = 3.36; 95% CI: 1.36–8.31). Risk within this group exceeded that of individuals with AHA-abnormal blood pressure.
Conclusion
Among pregnant individuals with first-trimester AHA-normal blood pressure, unsupervised clustering identified a distinct subgroup at elevated risk for preeclampsia and SGA. These findings suggest that conventional thresholds may overlook early vascular risk and support further investigation into machine learning-based risk stratification in pregnancy.
Key Points
-
Machine learning identified a distinct high-risk cluster (7.4%) within normotensive pregnancies.
-
This cluster had an eight-fold higher risk of preeclampsia and a three-fold increased risk of SGA neonate.
-
Machine learning may enhance early pregnancy risk stratification.
Keywords
preeclampsia - hypertensive disorders of pregnancy - blood pressure phenotype - machine learning - small for gestational age - risk stratification - American Heart Association - Pregnancy - hypertensionData Availability Statement
Data are available upon request from the authors.
Contributors' Statement
R.H.: Data curation, writing–original draft. E.K.: Formal analysis. E.S.: Data curation, investigation. A.Z.A.: Conceptualization, funding acquisition, investigation, supervision, writing–review and editing. G.S.: Conceptualization, funding acquisition, investigation, supervision, writing–review and editing.
Publication History
Received: 08 December 2025
Accepted: 30 December 2025
Accepted Manuscript online:
12 January 2026
Article published online:
29 January 2026
© 2026. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Say L, Chou D, Gemmill A. et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health 2014; 2 (06) e323-e333
- 2 Ford ND, Cox S, Ko JY. et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017-2019. MMWR Morb Mortal Wkly Rep 2022; 71 (17) 585-591
- 3 Davidson KW, Barry MJ, Mangione CM. et al; US Preventive Services Task Force. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 326 (12) 1186-1191
- 4 Henderson JT, Webber EM, Vesco KK, Thomas RG. Screening for Hypertensive Disorders of Pregnancy: An Evidence Update for the US Preventive Services Task Force. Evidence Synthesis No. 227. AHRQ Publication No. 22-05299-EF-1. Agency for Healthcare Research and Quality; 2023
- 5 American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 743: Low-dose aspirin use during pregnancy. Obstet Gynecol 2018; 132 (01) e44-e52
- 6 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71 (06) e13-e115 [ Erratum in: Hypertension. 2018 Jun;71(6):e140 – e144. doi: 10.1161/HYP.0000000000000076. PMID: 29133356]
- 7 Horgan R, Hage Diab Y, Bartal MF, Sibai BM, Saade G. Pregnancy outcomes among patients with stage 1 chronic hypertension. Am J Obstet Gynecol MFM 2024; 6 (03) 101261
- 8 American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135 (06) e237-e260
- 9 Hauspurg A, Parry S, Mercer BM. et al. Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women. Am J Obstet Gynecol 2019; 221 (03) 277.e1-277.e8
- 10 Bello NA, Zhou H, Cheetham TC. et al. Prevalence of hypertension among pregnant women when using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines and association with maternal and fetal outcomes. JAMA Netw Open 2021; 4 (03) e213808
- 11 von Dadelszen P, Magee LA. Pre-eclampsia: An update. Curr Hypertens Rep 2014; 16 (08) 454
- 12 Levine RJ, Maynard SE, Qian C. et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350 (07) 672-683
- 13 Poon LC, Shennan A, Hyett JA. et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 2019; 145 suppl 1 (Suppl. 01) 1-33
- 14 Arain Z, Iliodromiti S, Slabaugh G, David AL, Chowdhury TT. Machine learning and disease prediction in obstetrics. Curr Res Physiol 2023; 6: 100099
- 15 Steinberg S, Wong M, Zimlichman E, Tsur A. Novel machine learning applications in peripartum care: A scoping review. Am J Obstet Gynecol MFM 2025; 7 (03) 101612
- 16 Kawakita T, Greenland P, Pemberton VL. et al. Prediction of metabolic syndrome following a first pregnancy. Am J Obstet Gynecol 2024; 231 (06) 649.e1-649.e19
- 17 Clapp MA, Kim E, James KE, Perlis RH, Kaimal AJ, McCoy Jr TH. Natural language processing of admission notes to predict severe maternal morbidity during the delivery encounter. Am J Obstet Gynecol 2022; 227 (03) 511.e1-511.e8
- 18 Schor JS, Kadambi A, Fulcher I. et al. Using machine learning to predict the risk of developing hypertensive disorders of pregnancy using a contemporary nulliparous cohort. AJOG Glob Rep 2024; 4 (04) 100386
- 19 Ansbacher-Feldman Z, Syngelaki A, Meiri H, Cirkin R, Nicolaides KH, Louzoun Y. Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers. Ultrasound Obstet Gynecol 2022; Dec; 60 (06) 739-745
